• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌预防

Breast cancer prevention.

作者信息

Euhus David M, Diaz Jennifer

机构信息

Department of Surgery, Johns Hopkins Hospital, Baltimore, Maryland.

出版信息

Breast J. 2015 Jan-Feb;21(1):76-81. doi: 10.1111/tbj.12352. Epub 2014 Nov 20.

DOI:10.1111/tbj.12352
PMID:25413630
Abstract

Breast cancer is the most common cancer in women with 232,670 new cases estimated in the USA for 2014. Approaches for reducing breast cancer risk include lifestyle modification, chemoprevention, and prophylactic surgery. Lifestyle modification has a variety of health benefits with few associated risks and is appropriate for all women regardless of breast cancer risk. Chemoprevention options have expanded rapidly, but most are directed at estrogen receptor positive breast cancer and uptake is low. Prophylactic surgery introduces significant additional risks of its own and is generally reserved for the highest risk women.

摘要

乳腺癌是女性中最常见的癌症,2014年美国估计有232,670例新发病例。降低乳腺癌风险的方法包括生活方式改变、化学预防和预防性手术。生活方式改变具有多种健康益处,且相关风险较小,适用于所有女性,无论其患乳腺癌的风险如何。化学预防的选择迅速增加,但大多数针对雌激素受体阳性乳腺癌,且接受率较低。预防性手术本身会带来显著的额外风险,通常仅适用于风险最高的女性。

相似文献

1
Breast cancer prevention.乳腺癌预防
Breast J. 2015 Jan-Feb;21(1):76-81. doi: 10.1111/tbj.12352. Epub 2014 Nov 20.
2
Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.高危女性及导管原位癌患者的乳腺癌化学预防
Breast J. 2015 Jul-Aug;21(4):377-86. doi: 10.1111/tbj.12418. Epub 2015 Apr 16.
3
Risk-reducing strategies for breast cancer--a review of recent literature.乳腺癌的风险降低策略——近期文献综述
Int J Fertil Womens Med. 2003 Nov-Dec;48(6):274-7.
4
Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial.优化内分泌方法以进行乳腺癌化学预防,超越他莫昔芬与雷洛昔芬研究(STAR)试验。
Eur J Cancer. 2006 Nov;42(17):2909-13. doi: 10.1016/j.ejca.2006.09.012. Epub 2006 Oct 24.
5
Chemoprevention of breast cancer.乳腺癌的化学预防
Expert Rev Anticancer Ther. 2008 Mar;8(3):443-52. doi: 10.1586/14737140.8.3.443.
6
Chemoprevention for breast cancer.乳腺癌的化学预防。
Cancer Treat Rev. 2012 Aug;38(5):329-39. doi: 10.1016/j.ctrv.2011.07.005.
7
Breast cancer prevention by antihormones and other drugs: where do we stand?抗激素和其他药物预防乳腺癌:我们处于什么位置?
Hematol Oncol Clin North Am. 2013 Aug;27(4):657-72, vii. doi: 10.1016/j.hoc.2013.05.009.
8
Addressing barriers to uptake of breast cancer chemoprevention for patients and providers.解决患者和医疗服务提供者在接受乳腺癌化学预防方面的障碍。
Am Soc Clin Oncol Educ Book. 2015:e50-8. doi: 10.14694/EdBook_AM.2015.35.e50.
9
The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.STAR试验:雷洛昔芬作为绝经后女性降低乳腺癌风险药物的证据。
J Natl Compr Canc Netw. 2007 Sep;5(8):719-24.
10
Chemoprevention of breast cancer.乳腺癌的化学预防
Lancet. 2006 Apr 29;367(9520):1382-3. doi: 10.1016/S0140-6736(06)68594-2.

引用本文的文献

1
Breast Cancer Screening and Prophylactic Mastectomy for High-Risk Women in Romania.罗马尼亚高危女性的乳腺癌筛查与预防性乳房切除术
Medicina (Kaunas). 2024 Mar 30;60(4):570. doi: 10.3390/medicina60040570.
2
Systemic and Local Strategies for Primary Prevention of Breast Cancer.乳腺癌一级预防的全身及局部策略
Cancers (Basel). 2024 Jan 5;16(2):248. doi: 10.3390/cancers16020248.
3
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study.社区妇女乳腺癌感知量表中文版的心理计量学评估:翻译与验证研究。
Breast Cancer. 2024 Jan;31(1):42-52. doi: 10.1007/s12282-023-01508-8. Epub 2023 Oct 13.
4
Implant-based Breast Reconstruction after Mastectomy for Breast Cancer: A Systematic Review and Meta-analysis.乳腺癌乳房切除术后基于植入物的乳房重建:一项系统评价和荟萃分析。
Plast Reconstr Surg Glob Open. 2022 Mar 18;10(3):e4179. doi: 10.1097/GOX.0000000000004179. eCollection 2022 Mar.
5
Breast Cancer Therapeutics and Biomarkers: Past, Present, and Future Approaches.乳腺癌治疗与生物标志物:过去、现在及未来的方法
Breast Cancer (Auckl). 2021 Mar 24;15:1178223421995854. doi: 10.1177/1178223421995854. eCollection 2021.
6
Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care.选择性雌激素受体调节剂(SERMs)降低乳腺癌风险的获益与危害:初级保健中沟通风险方法的横断面研究。
Br J Gen Pract. 2019 Nov 28;69(689):e836-e842. doi: 10.3399/bjgp19X706841. Print 2019 Dec.
7
Risk-reducing medications for primary breast cancer: a network meta-analysis.原发性乳腺癌的风险降低药物:一项网状荟萃分析。
Cochrane Database Syst Rev. 2019 Apr 29;4(4):CD012191. doi: 10.1002/14651858.CD012191.pub2.
8
Prophylactic mastectomy for the prevention of breast cancer: Review of the literature.预防性乳房切除术预防乳腺癌:文献综述
Avicenna J Med. 2018 Jul-Sep;8(3):67-77. doi: 10.4103/ajm.AJM_21_18.
9
Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis.基于网络药理学的 TAMS/CXCL-1 验证为消癌平方防治乳腺癌发生和转移的关键介质。
Sci Rep. 2017 Nov 6;7(1):14513. doi: 10.1038/s41598-017-15030-3.